Azacitidin Stada 150 mg, Pulver zur Herstellung einer Injektionssuspension - Swissmedic Key 69238002 Registration Holder Spirig HealthCare AG Name Azacitidin Stada 150 mg, Pulver zur Herstellung einer Injektionssuspension Date of registration 18.09.2023 Original/Generic Generic Introduction of Sequence 18.09.2023 ATC-Classification Azacitidine (L01BC07) Revision date WHO WHO-DDD Valid until 17.09.2028 Index Therapeuticus (BSV) 07.16.10. Show package size Index Therapeuticus (Swissmedic) 07.16.10. Description Swissmedic categorie. A SL Eintrag Yes Indication Information for professionals IP Consumer information Ex-factory-Price 304.64 Limitation Yes Limitation text
Deductible 10 % Consumer price 366.50 Feedback FB GTIN 7680692380029 Medication Code Synthetika Pharmacode Disponibility
Composition azacitidinum 150 mg, mannitolum, pro vitro. Packungsbestandteile Galenic Form Powder for injection suspension Excipiens Active Agent Dose Azacitidine 150 mg
BAG: Active Agent Dose Azacitidine 150 mg
Source Data was imported : 07.10.2023
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
